Isothermal Nucleic Acid Amplification Technology (INAAT) In Increasingly Becoming Popular As It Is Used For A Range Of Diagnostic Applications
Isothermal
amplification methods offer several advantages over other technologies. They
are inexpensive, have a high efficiency and can be automated. Their speed is
another advantage, however, speed isn't always a benefit. For example, PCR uses
a low-cost dye to detect amplification products, which may not be suitable for
some applications. Moreover, isothermal techniques are less expensive and may
require fewer samples. Isothermal nucleic acid amplification technology (INAAT)
can detect pathogens in environmental, clinical, and food samples. As a result,
they are ideal for diagnostic purposes, such as infection detection. Recent
studies show that this technology is useful for diagnosing diseases like HIV
and AIDS, and as it is unbiased, isothermal nucleic acid amplification
technology (INAAT) also provides higher amounts of DNA material for downstream
analysis. Also as this this technology is a fast and inexpensive method, it has
many other benefits as well.
The growth
of isothermal nucleic acid amplification technology (INAAT) is expected to be
driven by a number of factors. The geriatric population is projected to grow
significantly in the coming years, along with the growing healthcare
infrastructure. Furthermore, the technology can be used to detect rare diseases.
It is also useful for biotechnology companies to increase the production of
gene therapy drugs. The growing number of patients with chronic illnesses
worldwide is driving the demand for this technique.
Isothermal
Nucleic Acid Amplifiers are highly sensitive and reliable. The technology is
used for a range of diagnostic applications, including infectious diseases and
chronic diseases. The researchers who created this technique have been
published in a variety of scientific journals. Some of them have even published
a case study using this method to detect a rare pathogen in rivers. With
Isothermal Amplification Technology, doctors can quickly test a variety of
different organisms and diseases with minimal efforts. In February 2022, Seegene,
a Korean manufacturer of in vitro-diagnostic products received the CE-IVD mark
for its Allplex SARS-CoV-2 fast MDx Assay, an isothermal amplication test that
gives results in 30 minutes.
Comments
Post a Comment